Actualizado 26/06/2009 09:46
- Comunicado -

Boehringer Ingelheim Receives Positive Recommendation From European Scientific Committee for a New Once Daily Mirapexin(

Contact: Ursula Bardon, Corporate Division Communications, Boehringer Ingelheim GmbH, 55216 Ingelheim/Germany, Phone: +49-6132-77 2622, Fax: +49-6132-72 2622, E-mail: press@boehringer-ingelheim.com

Contenido patrocinado